Regado BioSciences, Inc. (TBRA)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Laurent Fischer
Employees:
11
701 GATEWAY BLVD, SUITE 300, SOUTH SAN FRANCISCO, CA 94080
650-741-6625

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Regado Biosciences, Inc., a biopharmaceutical company, focuses on the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular and other indications.

Data derived from most recent annual or quarterly report
Market Cap 792.134 Million Shares Outstanding18.82 Million Avg 30-day Volume 230.832 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.36
Price to Revenue202.9139 Debt to Equity0.7681 EBITDA-60.195 Million
Price to Book Value11.9645 Operating Margin-5164.206 Enterprise Value210.879 Million
Current Ratio3.503 EPS Growth1.227 Quick Ratio3.362
1 Yr BETA 1.4359 52-week High/Low 0.0 / Profit Margin-4906.6094
Operating Cash Flow Growth-19.5611 Altman Z-Score-3.8323 Free Cash Flow to Firm -26.62 Million

Are you looking for this stock instead?

View SEC Filings from TBRA instead.

View recent insider trading info

Regado BioSciences, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding TBRA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TBRA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2016-11-04 by TIBIRA THERAPEUTICS, INC.
  • 4: filed on 2016-11-03 by TIBIRA THERAPEUTICS, INC.
  • 4: filed on 2016-11-03 by TIBIRA THERAPEUTICS, INC.
  • 4: filed on 2016-11-03 by TIBIRA THERAPEUTICS, INC.
  • 4: filed on 2016-11-03 by TIBIRA THERAPEUTICS, INC.
  • 4: filed on 2016-11-03 by TIBIRA THERAPEUTICS, INC.
  • 4: filed on 2016-11-03 by TIBIRA THERAPEUTICS, INC.
  • 4: filed on 2016-11-03 by TIBIRA THERAPEUTICS, INC.
  • 4: filed on 2016-11-03 by TIBIRA THERAPEUTICS, INC.
  • 4: filed on 2016-11-03 by TIBIRA THERAPEUTICS, INC.

    • Events (8k)

  • 8-K: filed on 2016-11-01:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-09-20:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-07-25:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-04-11:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-03-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    DOMAIN ASSOCIATES

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    VITULLO NICOLE

    HALAK BRIAN K

    KAMDAR KIM P.

    • 10% Owner
    		 No longer subject to file 2016-11-01 0

    DOMAIN PARTNERS VI, L.P.

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    VITULLO NICOLE

    • 10% Owner
    		 No longer subject to file 2016-11-01 0

    DP VI ASSOCIATES, L.P.

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    VITULLO NICOLE

    • 10% Owner
    		 No longer subject to file 2016-11-01 0

    DP VII ASSOCIATES LP

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    VITULLO NICOLE

    HALAK BRIAN K

    • 10% Owner
    		 No longer subject to file 2016-11-01 0

    DOMAIN PARTERS VII L P

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    VITULLO NICOLE

    HALAK BRIAN K

    • 10% Owner
    		 No longer subject to file 2016-11-01 0

    WEBER ECKARD

    • Director
    		 No longer subject to file 2016-11-01 0

    COOPER JEFFREY H

    • Director
    		 No longer subject to file 2016-11-01 0

    PODLESAK DENNIS

    • Director
    		 No longer subject to file 2016-11-01 0

    FRAZIER HEALTHCARE V, LP

    • 10% Owner
    		 No longer subject to file 2016-11-01 0

    FROMKIN ANDREW J.

    • Director
    		 No longer subject to file 2016-11-01 0

    HERON PATRICK J

    • Director
    		 No longer subject to file 2016-11-01 0

    FISCHER LAURENT CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 No longer subject to file 2016-11-01 0

    LEGAULT PIERRE

    • Director
    		 No longer subject to file 2016-11-01 0

    BROSGART CAROL L

    • Director
    		 No longer subject to file 2016-11-01 0

    JENKINS HELEN CHIEF OPERATING OFFICER

    • Officer
    		 No longer subject to file 2016-11-01 0

    PEETZ CHRISTOPHER CHIEF FINANCIAL OFFICER

    • Officer
    		 No longer subject to file 2016-11-01 0

    LEFEBVRE ERIC CHIEF MEDICAL OFFICER

    • Officer
    		 No longer subject to file 2016-11-01 0

    MELINCOFF GWEN A

    • Director
    		 No longer subject to file 2016-11-01 0

    PENTWATER CAPITAL MANAGEMENT LP

    • 10% Owner
    		 3,758,200 2016-10-31 0

    ALLERGAN PLC

    ALLERGAN HOLDCO US, INC.

    SAPPHIRE ACQUISITION CORP.

    • 10% Owner
    		 0 2016-09-19 0

    NOVO A/S

    • 10% Owner
    		 No longer subject to file 2016-07-11 0

    DOMAIN ASSOCIATES

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    SCHOEMAKER KATHLEEN K

    VITULLO NICOLE

    HALAK BRIAN K

    KAMDAR KIM P.

    • 10% Owner
    		 38,094 2015-05-04 0

    DP VII ASSOCIATES LP

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    SCHOEMAKER KATHLEEN K

    VITULLO NICOLE

    HALAK BRIAN K

    • 10% Owner
    		 47,613 2015-05-04 0

    DOMAIN PARTERS VII L P

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    SCHOEMAKER KATHLEEN K

    VITULLO NICOLE

    HALAK BRIAN K

    • 10% Owner
    		 3,553,322 2015-05-04 0

    TREU JESSE I

    • Director
    • 10% Owner
    		 0 2015-01-01 0

    NEFF P SHERRILL

    • Director
    		 0 2015-01-01 0

    ELSEY R DON SR. VP/CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2015-01-01 0

    CLARK B. JEFFERSON

    • Director
    		 0 2015-01-01 0

    GOPKA ANTON

    • Director
    		 0 2015-01-01 0

    MENDELSOHN MICHAEL

    • Director
    		 0 2015-01-01 0

    SHAH NIMESH

    • 10% Owner
    		 38,094 2015-01-01 0

    METZGER MICHAEL A PRESIDENT & CEO

    • Officer
    • Director
    		 0 2014-12-03 0

    KIERLIN ROBERT A

    • 10% Owner
    		 No longer subject to file 2014-10-24 0

    PELLICCIONE NICHOLAS J. SR. VP OF REGULATORY AFFAIRS

    • Officer
    		 0 2014-05-21 0

    BVF PARTNERS L P/IL

    BIOTECHNOLOGY VALUE FUND L P

    BIOTECHNOLOGY VALUE FUND II LP

    BVF INC/IL

    LAMPERT MARK N

    • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
    		 No longer subject to file 2014-03-21 0

    MAZZO DAVID J CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2014-01-01 0

    WISNIEWSKI RAPHAEL

    • Director
    		 0 2014-01-01 0

    GIAQUINTO ALEXANDER R CCO, SVP OF REG. AFFAIRS

    • Officer
    		 0 2014-01-01 0

    ZELENKOFSKE STEVEN SVP & CHIEF MEDICAL OFFICER

    • Officer
    		 0 2014-01-01 0

    COURTS CHRISTOPHER VICE PRESIDENT OF FINANCE

    • Officer
    		 0 2014-01-01 0

    RUSCONI CHRISTOPHER PAUL CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2014-01-01 0

    BLAIR JAMES C

    • 10% Owner
    		 2,603,208 2013-08-27 0

    QUAKER BIO VENTURES LP

    QUAKER BIOVENTURES CAPITAL LP

    • 10% Owner
    		 1,294,021 2013-08-27 0

    VITULLO NICOLE

    • 10% Owner
    		 2,603,208 2013-08-27 0

    DOVEY BRIAN H

    • 10% Owner
    		 2,603,208 2013-08-27 0

    SCHOEMAKER KATHLEEN K

    • 10% Owner
    		 2,603,208 2013-08-27 0

    DOMAIN PARTNERS VI, L.P.

    • 10% Owner
    		 2,571,117 2013-08-27 0

    DP VI ASSOCIATES, L.P.

    • 10% Owner
    		 14,920 2013-08-27 0

    MCDONALD ELLEN SVP & CHIEF BUSINESS OFFICER

    • Officer
    		 0 2013-08-27 0

    BIODISCOVERY 3, FCPR

    EDMOND DE ROTHSCHILD INVESTMENT PARTNERS

    • 10% Owner
    		 2,407,271 2013-08-27 0

    RMI INVESTMENTS S.A.R.L.

    RUSNANOMEDINVEST LLC

    • 10% Owner
    		 5,236,517 2013-08-27 0

    DOMAIN ASSOCIATES

    • 10% Owner
    		 17,171 2013-08-21 0

    HALAK BRIAN K

    • 10% Owner
    		 17,171 2013-08-21 0

    KAMDAR KIM P.

    • 10% Owner
    		 17,171 2013-08-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    WISNIEWSKI RAPHAEL - Director - > 10% Owner

    		2013-08-29 16:37:27 -0400 2023-08-27 A 17,964 a 17,964 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments